This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

ExuFlex01 Post Market Clinical Follow-up Investigation

  • Research type

    Research Study

  • Full title

    Prospective, open, non-comparative, multi-centre, post market clinical follow-up (PMCF) investigation to follow the progress of exuding chronic wounds to healing using Exufiber® as primary dressing, and Mepilex® Border Flex (Mepilex Border Comfort).

  • IRAS ID

    294116

  • Contact name

    Paul Chadwick

  • Contact email

    paul.chadwick@cop.org.uk

  • Duration of Study in the UK

    0 years, 9 months, 12 days

  • Research summary

    The overall objective of this post market clinical follow-up (PMCF) investigation is to follow the progress of exuding chronic wounds to healing, or up to 12 weeks, whichever occurs first, consecutively using Exufiber® as primary dressing, and Mepilex® Border Flex (Mepilex Border Comfort) as primary dressing.

  • REC name

    London - Westminster Research Ethics Committee

  • REC reference

    21/LO/0113

  • Date of REC Opinion

    12 Mar 2021

  • REC opinion

    Further Information Favourable Opinion